1
101/12/22
Tw-DRGs
-
2
3
(System Integration)
(B
un
dlin
g Paym
ent)
()
()
()
(P
ay fo
r Pe
rform
an
ce)
4
(1998.7)
(1999.7)
(2002.7)
(2001.7)
(2003)
1995 FFS+Case payment
+
1998-2002 Global Budget
2004 RBRVS
2010 Tw-DRGs
164
2011 Capitation
Plan
()
(2001)
(2006)
BC(2010)
(CKD) (2011)
(2012)
(2003.3)
(2009)
(2011)
5
(Bundling Payment)
84-
(Fee for service)
(Case Payment)
(per-diem)
87-(Global Budget Payment)
99-
Tw-DRGs
()
100-
6
(Pay for Performance)
90-959791.81%
95-
99-BC
100-CKD
101-
7
(System Integration)
IDS
8
Tw-DRGs
9
Tw-DRGs
()
()
10
DRGs
DRGs-(Diagnosis Related Groups)
11
DRGs
DRG
DRG1
DRG2
DRG3 DRG4 DRG5
DRGn
DRGVariance
MDC
1029 25MDC+PREMDC
RW1 RW2
12
(Principal Diagnosis)
13
(Principal procedure)
14
/
/Comorbidity
Ex: Fracture of femur, DM
Complication
Ex:S/P Appendectomy, Wound infection
15
MDC(Major Diagnostic Category)
MDC 1
PRE 13
1 87
2 6 36
3 11 52
4 82
5 48 110
6 24 109
7 4 28
8 37 135
9 6 41
10 1 35
11 4 44
12 2 29
13 12 29
14 9 32
15 19
16 24
17 15
18 20
21 28
22 31
23 12
24 8
UN 10
164 1029 16
Tw-DRGs
Age
1 preMDC
25 MDCs
ICD-9-CM
ICD-9-CM
CC
CC
Alive
Death
1540.0()47.01() DRG16401/16501(/)RW1.5055/1.1378
2402.01()+37.21()DRG124/125(/) RW1.2724/0.9569
17
Tw-DRGs -
Tw-DRG
18
Tw-DRGs
MDC1920()
>30
ECMO(39.65)
19
, 3.21%
, 13.19%
, 2.34%
, 0.03%
, 0.16%
, 0.26%>30, 19.47%
, 0.42%
(), 1.20%
DRG, 60.7%
DRG
=DRG/
20
- DRG
DRG2MDC14()DRG
()
IABP(Intra-aortic balloon pump)
21
DRG DRG+
*0.8
= DRG
Tw-DRGs
(RW)(SPR) (1+CMI
)
(DRG91)
DRG2.5
22
A B C
50 91
Tw-DRGs
23
Tw-DRGs(RW)
Tw-DRGs RW=
DRG
97DRGDRG
DRGDRG
102-35,920 24
DRGMDC DRG%
DRGDRG%
%
1
98.12.17155DRG (11MDC)
28.60% 28.60% 17.36%
2 ()
MDC 58121314 ()
18.00% 46.60% 10.97%
3 ()
MDC 2367910 ()
14.30% 60.90% 10.26%
4 ()
MDC PRE411172324PRE MDC)
21.40% 82.30% 12.97%
5 ()
MDC 11516182122()
17.70% 100.00% 9.16%
1017DRG 100.00% 60.72%
100.01.01164 49
25
100.01.011,029
DRG
1. 2.
1.
2.
1. 2.
1. 2. 3.
DRG
26
DRG
DRG5.64%1.281
DRG4.38%0.27%
%
2009 1~2 1,353,802 -- 82,381 -- 231,241 17.08% -- 12,165 14.77%
--
2010 1~2 1,387,755 2.51% 82,735 0.43% 223,813 16.13% -3.21%
12,416 15.01% 2.06%
2011 1~2 1,439,131 3.70% 86,869 5.00% 227,773 15.83% 1.77%
12,449 14.33% 0.27%
2012 1~2 1,445,785 0.46% 87,100 0.27% 240,616 16.64% 5.64%
12,994 14.92% 4.38%
DRG
()
()
()
DRG
()
27
DRG-
28
29
DRG20121-24.14
4.426.25%4.18
1.09%
1011-23.13%
0.02%3.99-4.22
/%
2009 1~2 4.42 -- 4.51 -- 4.40 -- 4.30 --
2010 1~2 4.18 -5.26% 4.23 -6.15% 4.16 -5.42% 4.15 -3.57%
2011 1~2 4.18 0.03% 4.22 -0.28% 4.19 0.71% 4.12 -0.80%
2012 1~2 4.14 -1.09% 4.22 -0.02% 4.15 -0.88% 3.99 -3.13%
1 4.13 -1.06% 4.21 -0.19% 4.15 -0.73% 3.96 -3.04%
2 4.15 -1.10% 4.22 0.13% 4.16 -1.01% 4.01 -3.19%
30
45,97720121-245,2876900.02% 1.10%0.37%1.49%
/%
2009 1~2 45,977 -- 56,142 -- 42,852 -- 35,495 --
2010 1~2 45,609 -0.80% 55,632 -0.91% 42,151 -1.64% 35,620
0.35%
2011 1~2 45,298 -0.68% 55,257 -0.67% 42,356 0.49% 34,840
-2.19%
2012 1~2 45,287 -0.02% 56,080 1.49% 42,198 -0.37% 34,457
-1.10%
1 44,805 -0.08% 55,603 1.03% 41,838 -0.33% 33,824 -0.39%
2 45,754 0.06% 56,534 1.94% 42,550 -0.38% 35,070 -1.66%
DRG
20121-254,0026521,394 20121-22012CMI
/%
2009 1~2 52,608 62,858 49,129 42,664
2010 1~2 55,474 66,276 51,445 45,343
2011 1~2 54,654 65,437 50,938 44,412
2012 1~2 54,002 65,402 50,169 43,677
1 53,442 64,870 49,721 42,965
2 54,543 65,908 50,608 44,367
31
DRG
DRG20121-21.1924DRG 1.2676
1.18891.1662
/%
2009 1~2 1.1442 1.1196 1.1465 1.2020
2010 1~2 1.2163 1.1913 1.2205 1.2730
2011 1~2 1.2065 1.1842 1.2026 1.2748
2012 1~2 1.1924 1.1662 1.1889 1.2676
1 1.1928 1.1667 1.1884 1.2702
2 1.1921 1.1658 1.1894 1.2651
32
DRG-
33
1
120121-26107412.13%201023.79%20109Tw-DRGs 17.40%
8.80%2.09%
/%
2009 1~2 684 -- 842 -- 727 -- 333 --
2010 1~2 847 23.79% 1,014 20.44% 881 21.10% 486 46.03%
2011 1~2 695 -17.96% 960 -5.36% 651 -26.16% 346 -28.90%
2012 1~2 610 -12.13% 876 -8.80% 537 -17.40% 339 -2.09%
1 621 -16.93% 904 -13.67% 542 -22.47% 337 -5.47%
2 600 -7.03% 848 -3.59% 533 -11.96% 340 1.29%
34
1
120121-21,19665.51%1 6.03%4.92%
/%
2009 1~2 1,190 -- 1,287 -- 1,237 -- 938 --
2010 1~2 1,208 1.56% 1,307 1.55% 1,240 0.23% 973 3.80%
2011 1~2 1,266 4.75% 1,380 5.65% 1,302 5.05% 1,001 2.84%
2012 1~2 1,196 -5.51% 1,317 -4.58% 1,224 -6.03% 952 -4.92%
1 1,165 -5.70% 1,304 -0.16% 1,183 -8.60% 915 -8.58%
2 1,226 -5.24% 1,330 -8.19% 1,264 -3.51% 987 -1.37%
35
DRG
DRG20121-213.88%7.59%201040.37%DRG2011-2012
13.73%9.21%2.39%
%
2009 1~2 11.27% -- 12.62% -- 12.89% -- 6.37% --
2010 1~2 15.82% 40.37% 17.79% 40.97% 17.22% 33.59% 10.26%
61.07%
2011 1~2 15.02% -5.06% 18.41% 3.49% 15.86% -7.90% 9.18%
-10.53%
2012 1~2 13.88% -7.59% 17.97% -2.39% 14.40% -9.21% 7.92%
-13.73%
1 13.91% -7.45% 17.95% -1.10% 14.61% -8.34% 7.73% -18.63%
2 13.86% -7.60% 18.00% -3.59% 14.19% -10.13% 8.12% -8.46%
36
-()
37
DRG
38
DRG20121-20.24%14.3%552.94%
=/DRG
%
2009 1~2 0.35% -- 800 --
2010 1~2 0.34% -2.9% 757 -5.4%
2011 1~2 0.28% -17.6% 639 -15.6%
2012 1~2 0.24% -14.3% 584 -8.6%
1 0.24% -25.0% 288 -17.0%
2 0.24% -4.0% 296 1.4% %
2009 1~2 0.31% -- 258 -- 0.36% -- 356 -- 0.38% -- 183 --
2010 1~2 0.29% -6.5% 234 -9.3% 0.34% -5.6% 329 -7.6% 0.42%
10.53% 194 6.0%
2011 1~2 0.20% -31.0% 158 -32.5% 0.32% -5.9% 315 -4.3% 0.34%
-19.05% 166 -14.4%
2012 1~2 0.17% -15.0% 139 -12.0% 0.25% -21.9% 261 -17.1% 0.35%
2.94% 184 10.8%
1 0.16% -38.5% 67 -33.0% 0.27% -18.2% 139 -13.1% 0.31% -16.22%
82 -5.7%
2 0.17% 21.4% 72 24.1% 0.23% -23.3% 122 -21.3% 0.38% 18.75% 102
29.1%
-
39
3
40
320121-21.57%1.9%3,6433,7751321374.3%108
%
2009 1~2 1.57% -- 3,638 --
2010 1~2 1.68% 7.01% 3,768 3.57%
2011 1~2 1.60% -4.8% 3,643 -3.3%
2012 1~2 1.57% -1.9% 3,775 3.6%
1 1.50% -5.7% 1,774 1.4%
2 1.64% 2.5% 2,001 5.7%%
2009 1~2 1.62% -- 1,337 -- 1.76% -- 1,751 -- 1.12% -- 542 --
2010 1~2 1.77% 9.26% 1,413 5.68% 1.78% 1.14% 1,735 -0.91% 1.33%
18.75% 620 14.39%
2011 1~2 1.64% -7.3% 1,319 -6.7% 1.69% -5.1% 1,674 -3.5% 1.34%
0.8% 650 4.8%
2012 1~2 1.71% 4.3% 1,427 8.2% 1.62% -4.1% 1,691 1.0% 1.24%
-7.5% 657 1.1%
1 1.65% 6.5% 674 12.7% 1.54% -11.5% 796 -4.6% 1.16% -14.7% 304
-4.4%
2 1.78% 2.9% 753 4.4% 1.70% 3.7% 895 6.5% 1.31% -0.8% 353
6.3%
14
41
1420121-22.09%12.9%5,4745,04243235717.1%258
%
2009 1~2 2.33% -- 5,399 --
2010 1~2 2.66% 14.2% 5,957 10.3%
2011 1~2 2.40% -9.8% 5,474 -8.1%
2012 1~2 2.09% -12.9% 5,042 -7.9%
1 2.09% -15.0% 2,477 -8.2%
2 2.10% -10.6% 2,565 -7.6%
%
2009 1~2 2.25% -- 1,854 -- 2.59% -- 2,584 -- 1.97% -- 954 --
2010 1~2 2.59% 15.1% 2,066 11.4% 2.91% 12.4% 2,832 9.6% 2.28%
15.7% 1,059 11.0%
2011 1~2 2.28% -12.0% 1,828 -11.5% 2.76% -5.2% 2,738 -3.3% 1.87%
-18.0% 908 -14.3%
2012 1~2 1.89% -17.1% 1,570 -14.1% 2.46% -10.9% 2,563 -6.4%
1.71% -8.6% 909 0.1%
1 1.86% -19.1% 759 -14.2% 2.50% -11.7% 1,290 -4.8% 1.63% -16.8%
428 -6.8%
2 1.91% -15.5% 811 -14.0% 2.42% -10.4% 1,273 -8.0% 1.78% -0.6%
481 7.1%
CMI
CMI20121-21.37260.9%DRG7.59% CMI1.59471.30051.1667
/%
2009 1~2 1.3655 -- 1.5788 -- 1.2896 -- 1.1661 --
2010 1~2 1.3933 2.0% 1.6150 2.3% 1.3112 1.7% 1.1841 1.5%
2011 1~2 1.3850 -0.6% 1.6035 -0.7% 1.3117 0.0% 1.1732 -0.9%
2012 1~2 1.3726 -0.9% 1.5947 -0.5% 1.3005 -0.9% 1.1667 -0.6%
1 1.3589 -1.1% 1.5816 -1.2% 1.2896 -1.1% 1.1483 0.0%
2 1.3863 -0.6% 1.6080 0.1% 1.3112 -0.6% 1.1845 -1.0%
42
-1
Tw-DRGs
DRG1.09%
0.02%
(DRG)
DRG1.1924
20121-2DRG2009
43
-2
DRG 20121-20.24%
14.3%55
216
3142010
2011-2012
44
Tw-DRGs
ICD-10-
CM/PCS
Tw-DRGs
45
46 46
47
9812
18762
48 48
100
49
19 71 100 190
(%) 10% 37% 53% 100%
232,596 217,431 103,677 553,704
42% 39% 19% 100%
164,391 146,778 69,488 380,657
(%)
71% 68% 67% 69%
=/
(1/2)
(%)
553,704 100%
102,654 19%
23,780 4%
92,518 17%
2 0%
380,657 69%
285,163 75%
95,494 25%
198,566 52%
182,091 48%
55100412
38 75%25%
52%48%
50
(2/2)
51
(%)
380,657 100%
15 20,483 5% 15~30 8,989 2% 30~45 26,962 7% 45~65 146,838 39%
65~80 118,516 31% 80 58,869 15%
76,141 20%
1 181,806 48% 2 83,352 22% 3 28,145 7% 4 8,261 2%
5 2,952 1%
45~65
39%65-80
31%80
16%
148%
222%
310%
100
(99412)
(100412)
(%)
1.198 1.048 -12.46 %
4,083 3,951 -3.23 %
5.094 4.960 -2.63 %
0.040 0.035 -12.31 %
52
3.7
53
-30.000
-20.000
-10.000
0.000
10.000
20.000
30.000
0 5 10 15 20
(
)
() -12.0
-10.0
-8.0
-6.0
-4.0
-2.0
0.0
2.0
0 5 10 15 20
()
()
-30.0
-20.0
-10.0
0.0
10.0
0 5 10 15 20
(
)
() -40.0
-30.0
-20.0
-10.0
0.0
0 5 10 15 20
(
)
()
54
-40.000
-30.000
-20.000
-10.000
0.000
10.000
20.000
30.000
0 20 40 60 80
(
)
()
-15.00
-10.00
-5.00
0.00
5.00
10.00
0 10 20 30 40 50 60 70 80
(
)
()
-30.0
-20.0
-10.0
0.0
10.0
0 20 40 60 80
()
() -40.0
-30.0
-20.0
-10.0
0.0
0 10 20 30 40 50 60 70 80
(
)
()
55
-150.0
-100.0
-50.0
0.0
50.0
100.0
150.0
200.0
0 20 40 60 80 100
(
)
() -40.00
-20.00
0.00
20.00
40.00
60.00
80.00
0 20 40 60 80 100 120
(
)
()
-60.0
-40.0
-20.0
0.0
20.0
0 20 40 60 80 100 120
(
)
()
-60.0
-40.0
-20.0
0.0
20.0
0 20 40 60 80 100 120
(
)
()
100_(1/4)
56
3.36
2.81 2.47
2.07 1.94
1.62 1.46
1.24 1.00
0.90 0.89
0.80
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
1 2 3 4 5
-16.4%
(%)
-16.3%
-16.5%
-14.8%
-9.7%
-10.8%
57
2,512 2,433
4,036 3,960
4,831 4,623
5,560 5,233
6,007 5,702
6,951 6,498
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
1 2 3 4 5
-5.9%
-6.5%
-5.1%
-3.2%
-4.3%
-1.9%
(%)
100_(2/4)
58
3.90 3.87
4.61 4.55
5.93 5.69
7.30 6.92
8.69 8.18
10.95 10.24
0.00
2.00
4.00
6.00
8.00
10.00
12.00
1 2 3 4 5
(%)
-6.5%
-5.9%
-5.3%-4.0%
-1.4%
-0.8%
100_(3/4)
0.037 0.033 0.030 0.028
0.048 0.041
0.067
0.053
0.084
0.067
0.112
0.087
0.000
0.020
0.040
0.060
0.080
0.100
0.120
1 2 3 4 5
(%)
-21.8%
-19.8%
-20.8%-13.7%
-6.4%-13.1%
59
100_(4/4)
1004~12
(%)
1_ 176 94.1%
()
23.3
2_
184 98.4%
()
44.5
60
1921871
10010~12186
3_ 169 90.4%
() 14.7
4_ 160 85.6%
() 18.7
5_ 178 95.2%
() 32.3
186 99.5%
100
100Q1 100(Q2-Q4) 100 ()
()
()
()
15.9 20.4 53.7 90.0
6.6 7.6 17.1 31.2
10.2 12.3 24.3 46.8
4.7 8.2 16.2 29.2
8.3 5.1 18.8 32.3
1.4 1.8 3.5 6.7
47.2 55.5 133.6 236.2
61
99100Q1100Q147.2
100412(Q2Q4)55.5133.6
101(1/2)
100400
()150
2
43
1. ()
150200
2. ()
150
3. ()
100150 62
3
(994~1003)
(1004~1013)
63
101(2/2)
101
64
(A)
(C)
(D)
36 182,321 10,474 4,606 197,401
37 72,454 398 277 73,129
43 70,196 466 3,093 73,755
32 58,521 1,709 1,069 61,299
37 43,519 432 1,558 45,509
8 10,955 0 196 11,151
193 437,966 13,479 10,799 462,244
193B33,882
65
(111)
()
99%()
(
2
101
66
67 67
Leavell and Clarks (1)
(Primary Prevention)
68
Leavell and Clarks (2)
(Secondary Prevention)
(Tertiary Prevention)
69
100126
42
44
70
71
(1)
72
(2)
44
73
3
10071103630
10111031231
100101 3
74
-
-
(100)
(100)
75
76
()
77
(1)
78
(2)
()
79
-
:
:
80
-
:
:
81
-
:
:
()
()
82
3
83
()
(1++)
84
(60%)6
=()60%
(40%)4
=()40%
85
=()(1-) 50%1
86
(1)
10%20%
()
250% (540%
8%)
87
(2)
()10%
80%()10%70%-79%5%
10%20%
65
88
89
310033110()
4-5
515100515
5-6
71
90
5 20,094
6 30,014
7 8,664
157,084
15,614
( 5
)
61,923
4 5,976
1 14,799
2
7
3 5
91
:
:()
:
92
()() -5%() 10%
10%
8%
(HbA1c) 8%
(Fasting Lipid
Profile) 8%
8%
8%
10%
10%
65 10%
.80%20%
93
100Q3~101Q1()
.100Q3-101Q1101Q1
: :
_A -20.7% -11.1% -7.0% 10.4%
_B -20.3% -10.2% -0.1% 18.3%
_C -26.2% -13.1% -4.1% 3.8%
-28.5% -19.6%
_A -8.6% 5.6% -13.8% -3.7%
_B 25.6% 7.6% 18.6% 29.2%
_C -1.0% 5.6% -9.0% 42.9%
94
100Q3~101Q1()
.100Q3-101Q1101Q1
25%5
_A -5.5% -1.7% 7.9% 29.8%
_B -0.7% -0.8% 11.5% 31.3%
_C 0.1% -1.7% 17.4% 37.1%
-8.5% 8.8% 10.1% 31.8%
_A -9.9% 0.4% -7.8% -0.1%
_B -5.8% 1.3% 3.8% 3.3%
_C -4.3% 2.4% 4.1% 15.4%
95
()
()() - 10%
28.80% 8%
(HbA1c) 86.55% 8%
(Fasting Lipid Profile)
62.89% 8%
30.32% 8%
32.50% 8%
26.58% 10%
65 31.60% 10%
.9971006
96
1011
.1(101Q1)3(100Q3-101Q1)
()() 7 -
7 6 85.71%
(HbA1c) 7 4 57.14%
(Fasting Lipid Profile)
7 6 85.71%
7 6 85.71%
7 6 85.71%
7 5 71.43%
65 7 3 42.86%
97
1011
80% 2 0 0
1 17.5% 3 3 100.0%
75 1 1 100.0%
75 3 2 66.7%
75 3 1 33.3%
DNR DNR 1 1 100.0%
25 1 0 0.0%
2.
15% 2 1 50.0%
1.17.5% 2.115%12.5%
98
()
99
(101)1637
100
101
(1/2) 1013:
:
: 3
:
35
102
:
711
(2/2)
103
-
104 104
105 105
(101.9)
(102)
BC
CKD
(99)
92%97
(100)
106 106
: 1.101 2.9581
BC
CKD
107 107
(1/2)
108
1.
2.
1.
2.
3.
HBA1C
LDL
(report)
5
109
6
BC
BC
(2/2)
-
110
40020080096()
400200800() 14
200200500()
()
1000150040%60%
BC 100100100500
111
95 96 97 98 99 100 101Q1
()
7.25 7.86 5.04 2.87 5.87 4.87 4.998
()
1.88 2.02 2.04 1.94 2.89 3.89 0.634
25.9% 25.7 40.5 67.4 49.3 79.77 12.69%
()
3.56 4.27 4.24 2.99 3.0 3.0 2.12
()
2.04 1.49 1.30 1.29 1.41 1.48 0.359
57.3
35 30.8% 42.7 46.9 49.26% 16.93%
193-100101Q1P
2P
112
95 96 97 98 99 100 101Q1
7.25 7.86 5.04 2.873 5.873 4.873 4.998
1.88 2.02 2.039 1.936 2.893 3.887 0.634
1.02 1.11 1.39 1.496 1.945 2.283 0.547
0.24 0.16 0.16 0.162 0.169 0.175 0.044 0.07 0.13 0.07 0.072
0.094 0.02
0.15 0.25 0.37 0.208 0.53 0.901 *3
0.43 0.431
0.044 1 0.147 0.347 *3 BC 0.03 0.087 0.023
25.9% 25.7 40.5 67.4 49.3% 79.77% 12.69%
1.
2.95-100101Q11013
3.P
113
95 96 97 98 99 100 101Q1
3.56 4.27 4.236 2.99 3.00 3.00 2.12
2.04 1.49 1.303 1.290 1.406 1.478 0.359
0.45 0.48 0.60 0.684 0.768 0.832 0.203
1.21 0.60 0.51 0.473 0.471 0.438 0.118
0.29 0.39 0.18 0.133 0.137 0.138 0.024
0.019 0.018
0.07 1 0.004 0.011 *3
BC 0.026 0.058 0.014
57.3 35 30.8% 42.7 46.9% 49.26% 16.93%
1. 2.95-100101Q11011-3 3.P
114
-()
115
94 95 96 97 98 99 100 100/99
101Q1
160,889 176,475 181,098 191,251 214,340 254,504 283,748 11.49%
212,137
184,269 190,671 140,464 119,645 115,788 115,423 115,600 0.15%
56,120
5,852 6,927 8,438 9,807 10,743 11,678 11,827 1.28% 10,196
98,960 123,392 76,667 54,698 54,481 65,528 20.28% 13,802
36,580 43,076 17.75% 28,606
BC
44,035 91,840 108.56% 36,580
351,010 473,033 453,392 397,370 395,569 516,701 593,061 14.78%
352,429
1 295 399BC
1 : :()
(BC)
2 997887(+12%)
-()
116
94 95 96 97 98 991 100 101Q1
23.52% 23.16% 24.67% 26.34% 27.56% 29.26%2 31.16% 23.51%
32.50% 34.78% 35.17% 31.29% 31.61% 47.02% 45.45% 52.33%
12.09% 12.98% 13.60% 14.64% 14.50% 14.62% 13.67% 15.29%
9.31% 6.54% 3.93% 2.65% 2.55% 2.94% 0.79%
40.65% 46.94% 30.73%
BC
9.83% 19.37% 18.70%
-()
117
94 95 96 97 98 99 100 101Q1
119,828 123,289 127,842 135,926 154,512 188,827 209,647
154,359
24.47% 23.77% 25.51% 27.61% 30.06% 31.30% 35.01% 16.84%
36,267 33,686 27,029 23,534 23,911 25,006 24,860 12,440
13.54% 13.93% 14.34% 14.60% 15.75% 21.73% 20.87% 23.54%
5,852 6,927 8,438 9,807 10,743 11,678 11,827 10,196
12.09% 12.98% 13.60% 14.64% 14.50% 14.62% 13.67% 15.29%
--- 25,138 30,821 18,709 19,621 26,140 5,988
--- 2.62% 3.16% 1.87% 1.92% 2.48% 0.77%
--- --- --- --- 35,585 41,846 27,679
--- --- --- --- 40.95% 54.8% 35.85%
BC
--- --- --- --- 23,580 55,580 22,520
--- --- --- --- 6.79% 15.11% 14.35%
1 :
:()(
BC)
2997887(+12%)
39999493
6099493602
-()
118
94 95 96 97 98 99 100 101Q1
43,897 54,717 54,410 56,408 61,007 66,866 74,561 57,849
14.84% 16.55% 19.67% 20.80% 20.01% 19.74% 21.79% 25.79%
150,778 159,302 114,610 97,228 92,672 91,038 91,203 43,748
44.50% 46.43% 48.12% 43.94% 40.96% 65.71% 63.03% 78.22%
98,960 98,305 45,865 36,007 34,870 39,393 7,815
9.31% 8.89% 3.98% 2.89% 2.69% 2.92% 0.77%
--- --- --- --- 995 1,230 927
--- --- --- --- 32.21% 17.6% 12.97%
BC
--- --- --- --- 20,645 36,366 14,060
--- --- --- --- 16.13% 26.36% 34.18%
1 : :()
(BC) 2997887(+12%) 39999493
6099493602
119
-(1/4)
HbA1C
47.1% 47.6%
57.7%
64.7% 64.6% 63.0% 62.5%
97.4% 99.3% 99.7% 99.8% 99.7% 99.6% 99.4%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0%
100.0%
94 95 96 97 98 99 100
14.3% 13.1% 14.6% 15.7% 16.9% 16.7% 15.6%
70.0% 66.4%
64.3% 64.4% 66.3% 68.7% 67.6%
94 95 96 97 98 99 100
6.7% 7.8% 11.7%
14.5% 17.3% 19.2%
21.4%
44.4% 47.8%
54.1% 57.5%
60.8% 63.7%
71.0%
94 95 96 97 98 99 100
94-99HBA1C9.5%66%
HBA1C9.5%
1HBA1C
53,911
7% 9,451 17.5%
7%~9.5% 26,304 48.8%
9.5% 18,156 33.7%
120
-(2/4)
9495-100
946.8 121
HbA1C7.0%() HbA1C9.5%() LDL130()
24.5%
32.8%
31.8%
32.9% 32.2%
31.9% 32.1%
20.0%
22.0%
24.0%
26.0%
28.0%
30.0%
32.0%
34.0%
94 95 96 97 98 99 100
29.8%
15.5% 14.0%
12.9% 12.2% 12.1% 11.9%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
94 95 96 97 98 99 100
65.8%
71.7%
76.3%
79.0% 79.5%
82.2%
83.7%
60.0%
65.0%
70.0%
75.0%
80.0%
85.0%
94 95 96 97 98 99 100
-(3/4)
121
94-100
48,796 295 0.60%
402,295 17,339 4.31%
208,186 7,455 3.58%
659,277 25,089 3.81%
94100(08902250)94~100ID()585403014031140391404024040340412404134049240493
-(4/4)
122
Kaplan-MeierLife table
98.62% 9998.40%
195.64% 9994.41%
290.35% 9989.07%
373.48% 9970.75%
434.82% 9933.79%
99
-
123
0.120.112
0.118 0.121
0.119
0.0630.056 0.054
0.0630.057
0
0.03
0.06
0.09
0.12
0.15
96 97 98 99 100
0.041
0.035 0.034 0.0370.028
0.019 0.017 0.015 0.018 0.0130
0.01
0.02
0.03
0.04
0.05
0.06
96 97 98 99 100
-(1/3)
()
()
()
()
124
125
3,502 3,627 3,589
3,297 3,551
2,552 2,721
2,841 2,823
2,936
-
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
96 97 98 99 100
5,722
5,900 5,897
5,642
5,929
5,123 5,335
5,578
5,664
5,783
4,600
4,800
5,000
5,200
5,400
5,600
5,800
6,000
96 97 98 99 100
5.65 5.70 5.70 5.70
5.67
4.70 4.82 4.90
5.07 5.11
0.00
1.00
2.00
3.00
4.00
5.00
6.00
96 97 98 99 100
-(2/3)
-
126
96100
48.84%
60.96%
33,688
15,505 16,456
-
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
6 1
SBP140mmHg SBP
-(1/5)
100
11 10
27 25
41 35
11 9
90 79
998174
127
-(2/5) 100
(A)
(B) (B/A)
55,330 32,708 59.11%
19,970 7,132 35.71%
10,440 292 2.80%
85,740 40,132 46.81%
4,052 2,325 57.38%
1,465 600 40.96%
509 19 3.73%
6,026 2,944 48.85%
91,766 43,076 46.94% :1.
2.9989,98936,58440.65% 128
-(3/5) 100
1.100__
__99
2.100_99
99 100 99 100
_
20% 1.3950 1.3285 Y 1.3107 1.2538 Y
_
20% 5.7% 4.1% Y 6.1% 4.6% Y
_
20% 19.1% 21.0% 48.3% 37.4% Y
_ 20% 23.6% 24.9% 111.3% 78.9% Y
_ 20% 21.7% 1.5% Y 22.8% 1.5% Y
_ 0.7% 0.5% Y 1.9% 1.0% Y
_
12.8658 13.6462 28.8890 23.8899 Y
_
23.8% 24.7% 67.4% 49.4% Y
_ 64.4% 62.5% 64.4% 62.5%
60% 100%
129
1. 1004307699~100 2. 2&2
99 42,603 128.0 21.7 4,145 50,917
100 42,556 129.7 23.1 4,056 54,389
-47 1.7 1.6 -89 3,472
-(4/5) 100
99 12,975 22,693 24.5 1,590 182.5 (80/)
140.6
188,899 30.1%
100 12,270 22,478 23.6 1,400 166.8 (74/)
135.9
192,724 28.5%
-705 -215 -0.9 -190 -15.7 (-6/)
-4.7
3,825 -1.6%
1. 1004307699~100
2. ID 3. = / 10043,076
-(5/5)
131
132
109 80.73% 26,832 48.13% 212
193 88.08% 17,569 47.90% 18
302 85.43% 44,401 48.04% 230
1.100
2.
3.
50
20
-BC(1/2)
133
99-100BC()
-BC(2/2)
68.8%
80.2%
97.6% 97.5%
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
120.0%
99 100
GOT
72.7%
84.6%
98.2% 98.1%
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
120.0%
99 100
GPT
65.4%
75.2%
97.4% 97.0%
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
120.0%
99 100
59.3 HBA1C99.47% (HbA1C9.5%) 66% 2-3 48.84%()60.96%()
11.6 0.9 BCGOTGPT
134
135
136
137
1.
2. 3. 4.DRGs
1. 2. 3. 4.
5.
6.
1.
2.
(4)(4-6)
(7)
138
100101480
139
140
-1
A B C
141
-2
142
143
PHE
144
100-1018(99-101)99411013311001,704
145
10032910010310116101411
146
9910010012100996.217%16%
10010010%17%
147
DA
148
110168
2
()
()
()
96 01-12 637.0 718 44.8% 215.0 7,481 14.0% 852.0 930 28.8%
5.12% 2.28% -0.68% -1.56% -3.48% -4.52% 3.35% 0.58% -1.00%
97 01-12 695.7 769 45.6% 225.8 7,763 14.1% 921.5 986 29.5%
9.21% 7.10% 1.69% 5.01% 3.76% 0.96% 8.15% 6.09% 2.38%
98 01-12 736.5 784 45.2% 230.4 7,723 14.0% 966.9 997 29.5%
5.87% 1.99% -0.75% 2.02% -0.51% -0.93% 4.93% 1.12% 0.14%
99 01-12 755.6 786 44.4% 224.9 7,379 13.4% 980.5 988 29.0%
2.58% 0.17% -1.77% -2.36% -4.45% -4.10% 1.41% -0.97% -1.66%
100 01-12 829.6 836 45.3% 241.4 7,759 13.9% 1,071.0 1,046
30.1%
9.79% 6.37% 1.93% 7.33% 5.14% 4.08% 9.23% 5.86% 3.60%
149
-1
CTMRI90CTMRI
ESWL
150
-2
ACT code (AIDSBC)
Tygacil(B024443248)18
151
100702915263,0510.01%
152
153
1
100241.2
30%1,443
10024515 1002.8
26
20
20
ICDRGICD-10-CM/PCS
154
1.
2.
3.
155
156
157
()-1
158
()-2
159
25
100 Potassium-sparing diureticsAldosterone antagonist
()-3
160
()-4
161
()-1
162
6
()-2
163
HbA1c
HbA1c
()-1
25
164
1.
2.
3.
4.24
7 3,778 1,389 2,989 1,333 2,810 353
53,810 18,508 31,065 17,592 30,293 6,102
7 7.02% 7.50% 9.62% 7.58% 9.28% 5.78%
7 3,018 1,092 2,282 915 2,078 282
45,756 16,206 24,226 13,154 24,063 5,068
7 6.60% 6.74% 9.42% 6.96% 8.64% 5.56%
7 1,974 924 1,680 679 1,530 171
32,013 12,745 17,673 9,633 18,702 3,285
7 6.17% 7.25% 9.51% 7.05% 8.18% 5.21%
7 37,166 18,341 25,280 14,785 15,858 3,206
88,353 43,740 60,755 31,595 46,004 8,709
7 42.07% 41.93% 41.61% 46.80% 34.47% 36.81%
7 45,936 21,746 32,231 17,712 22,276 4,012
219,932 91,199 133,719 71,974 119,062 23,164
7 20.89% 23.84% 24.10% 24.61% 18.71% 17.32%
7 9,564 4,272 5,322 3,783 5,871 1,010
52,881 22,872 29,644 17,419 29,631 5,354
7 18.09% 18.68% 17.95% 21.72% 19.81% 18.86%
7 3,379 1,609 2,360 1,056 2,176 525
48,951 20,703 25,276 14,453 25,878 6,900
7 6.90% 7.77% 9.34% 7.31% 8.41% 7.61%
7 3,103 1,290 2,077 995 2,117 258
43,150 17,010 23,085 13,743 24,595 4,460
7 7.19% 7.58% 9.00% 7.24% 8.61% 5.78%
7 2,619 1,390 2,270 974 2,345 325
42,116 18,314 24,931 13,643 26,332 5,304
7 6.22% 7.59% 9.11% 7.14% 8.91% 6.13%
7 18,665 8,561 12,029 6,808 12,509 2,118
187,098 78,899 102,936 59,258 106,436 22,018
7 9.98% 10.85% 11.69% 11.49% 11.75% 9.62%
994
992
993
1.1 7
984
98
991
99
981
983
982
()-2
165
7
99~100
1009281002660194
()3
x(120%)(+)
(-)
-1
166
-2
()99100
()ATC
()6
()33()
167
-1
168
1 4.01% 983.27% 993.32% 1003.29%
2
8.59% 987.09% 997.10% 1006.99%
- 9821.30% 9921.99% 10022.67%
3 7
10.84% 9821.84% 9910.90% 1007.86%
4
1.16% 980.98% 990.89% 1000.78%
169
5 -
0.91% 990.76% 1000.75%
6 -
0.47% 990.39% 1000.39%
7 -
0.59% 990.49% 1000.48%
8 -
1.01% 990.84% 1000.85%
9 -
0.82% 990.68% 1000.68%
10 -
1.87% 991.56% 1001.53%
-2
1.99 2.3x(1+20%)
170
11 ()
- 991.92% 1001.86%
12 ()
- 990.69% 1000.67%
13 ()
- 991.22% 1001.14%
14
- 991.71% 1001.73%
15
- 991.95% 1001.88%
16
- 995.20% 1005.08%
-3
1.99 2.1
171
17
- 9936.18% 10039.17%
18
()
- 991.80% 1001.77%
()
- 999.33% 1008.10%
19
8.25% 997.19% 1007.14%
21 3.17% 982.61% 992.82% 1002.73%
23 3()
- 9916.50% 10014.76%
24 ESWL
1.271
%
981.14% 991.14% 1001.15%
-4
1.100 2.99
172
20 37.22% 9834.20% 9934.99%
10034.04%
22 20.93% 9820.39% 9920.68%
10019.38%
-5
173
174
RBRVS
175
176
